Critical Review: Vsee Health (NASDAQ:VSEE) vs. GeneDx (NASDAQ:WGS)

GeneDx (NASDAQ:WGS) and Vsee Health (NASDAQ:VSEE) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability and dividends.

Valuation & Earnings

This table compares GeneDx and Vsee Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GeneDx	$305.45 million	9.08	-$175.77 million	($1.96)	-51.53
Vsee Health	$6.38 million	0.87	-$4.41 million	N/A	N/A

Vsee Health has lower revenue, but higher earnings than GeneDx.

Profitability

This table compares GeneDx and Vsee Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GeneDx	-17.12%	3.33%	1.69%
Vsee Health	N/A	-182.59%	-58.26%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for GeneDx and Vsee Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GeneDx	0	3	3	0	2.50
Vsee Health	0	0	0	1	4.00

GeneDx presently has a consensus price target of $72.33, suggesting a potential downside of 28.38%. Vsee Health has a consensus price target of $5.00, suggesting a potential upside of 224.68%. Given Vsee Health’s stronger consensus rating and higher probable upside, analysts plainly believe Vsee Health is more favorable than GeneDx.

Insider & Institutional Ownership

61.7% of GeneDx shares are held by institutional investors. Comparatively, 1.0% of Vsee Health shares are held by institutional investors. 27.3% of GeneDx shares are held by company insiders. Comparatively, 6.6% of Vsee Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

GeneDx beats Vsee Health on 7 of the 12 factors compared between the two stocks.

About GeneDx

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

About Vsee Health

VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.